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Abstract
Background: The aim of the study was to describe the health-related quality of life of Canarian population using
information from the Canary Island Health Survey and three observational studies developed in the Canary Islands.
Methods: A descriptive analysis was carried out on a sample of 5.549 Canarian citizens using information from
2004 Canary Island Health Survey and three observational studies on Alzheimer’s disease, Stroke and HIV. EQ-5 D
was the generic tool used for revealing quality of life of people surveyed. Besides the rate of people reporting
moderate or severe decrease in quality of life, TTO-index scores and visual analogue scale were used for assessing
health related quality of life of people that suffer a specific diseases and general population.
Results: Self-perceived health status of citizens that suffer chronic diseases of high prevalence, identifies by the
Canary Island Health Survey and other diseases such Alzheimer’s disease, Stroke and HIV, independently examined
in observational studies, are worse than self-perceived health of general population. Depression/anxiety and pain/
discomfort were identified as the dimensions of the EQ-5 D with highest prevalence of problems. Alzheimer’s
disease and stroke were the illnesses with greater loss of quality of life.
Conclusions: Health related quality of life should be integrated into a set of information along with expectancy of
life, incidence and prevalence of chronic diseases for developing health policy and planning health care activities
The combination of information on health related quality of life from population health surveys with data from
observational studies enlarges the sources of relevant information for setting health priorities and assessing the
impact of health policies.
Background
Health is one of the main determinants of the welfare of
societies. Developed countries allocate a great amount
of monetary and non-monetary resources to the care of
their population health. Therefore, the measurement
and the analysis of the evolution of the health of a
population are relevant elements for health decision-
makers and for the society at large.
Traditionally, the health of a population has been
measured using epidemiological indicators, morbidity
(incidence and prevalence) and mortality [1]. Under the
traditional biomedical model of the disease, the mortal-
ity rate and the life expectancy at birth or life expec-
tancy at a given age have traditionally been used,
together with the infant mortality rate, as the main
indicators of populations’ health. Although the concept
of quality of life arose in the social science literature in
1920 [2], the World Health Organization’s (WHO) 1947
definition of health as “a state of complete physical,
mental and social welfare and not merely the absence of
disease or infirmity” [3] encourages a new “psycho-
social” model in which consideration is not only given
to the “amount of life” but also to the preferences and
perception on individuals about their own health, that
is, their quality of life [4,5].
Health related quality of life (HRQOL) is a multi-attri-
bute concept encompassing physical, mental, and social
dimensions. In last decades, quality of life has increased
in importance as a key health indicator for several rea-
sons [1]. First of all, it has become increasingly clear
that mortality reduction cannot be the only objective for
health care systems facing mostly chronic and degenera-
tive diseases. Secondly, it has also become clear that it is
t h ep a t i e n t ,n o tt h ep h y s i c i a n ,w h oh a st h ea u t h o r i t yt o
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economic evaluation methods of health care technolo-
gies has allowed and stimulated an increase in the inter-
est in subjective health and quality of life of patients. As
Sullivan notes [1], “Medicine’s epidemiological transition
from acute to chronic disease is thus prompting an epis-
temological transition from primarily objective to pri-
marily subjective evidence of health and health care
effectiveness. Now some of the most important patient
outcomes, like patient choices before them, are valid
because they are subjective”. Additionally, several studies
reveals that a worse HRQOL is associated with higher
mortality [6-9] and a greater use of healthcare services
[8,10,11].
Traditionally, populations’ health surveys include
questions on self-perceived health status, but recently
generic instruments, such ast h eE Q - 5D ,a r ei n c r e a s -
ingly included in these surveys for measuring HRQOL, .
EQ-5 D has been used in specific groups and in the
general population in several European countries, Japan,
and United States of America [12-17] and is commonly
used for describing the most commonly reported health
states, for establishing the health status in the commu-
nity, so that different population subgroups can be com-
pared, for studying the association between HRQOL and
age, sex, socio-economic status and disease groups, for
analyzing efficacy in randomized clinical trials and effi-
ciency in evaluations of health care technologies, and for
examining the association between HRQOL and mortal-
ity risk. Additionally, there is a substantial amount of lit-
erature on descriptive studies on the HRQOL in the
general population. However, very few studies have spe-
cifically reported HRQOL from representative samples
of the general population jointly with HRQOL data
from epidemiological studies focused on diseases of
lower prevalence that are not usually identified by gen-
eral health surveys.
The aim of this study was to describe the health-
related quality of life (HRQOL) of Canary Islands citi-
zens in the first years of XXI century. For this purpose,
we have combined information from the Canary Island
Health Survey jointly with information from observa-
tional studies.
Methods
Our primary sources of data were the Canary Island
Health Survey (CIHS) and three observational studies on
HIV/AIDS, Alzheimer’s disease and Stroke. The reason
that led us to combine these sources was to show a map
of the health status of the Canary Island population that
would be impossible to collect only with the information
contained in the Canary Island health survey since dis-
eases with devastating effects on human health but with
low prevalence at the population level, like HIV/AIDS,
Alzheimer’s disease and Stroke, are not captured ade-
quately by general health surveys, e.g. differences
between stages of the disease.
The CIHS was carried out in the year 2004, with a
sample of 4,320 adult people residing in Canary Islands
(an insular southwest region of Spain with more than 2
millions inhabitants in 2008, the 4.5 per cent of the
total population of Spain). The survey included ques-
tions on self-perceived health status, chronic morbidity,
habits (including feeding, physical exercise and tobacco
and alcohol consumption) and socio-demographics vari-
ables (as age, gender, educational level, occupation sta-
tus). We focused our interest in the most prevalent
health problems according CIHS: Diabetes mellitus,
rheumatism-arthritis and degenerative osteoarthritis,
back pain, heart problems, osteoporosis, anxiety/depres-
sion, respiratory and digestive diseases.
The three observational studies included were carried
out on behalf of the Canary Islands Health Service. The
study on Alzheimer’sd i s e a s e(AD) was a cross-sec-
tional observational study with a sample of 237 patients
with AD. The interviewees lived in the Canary Islands
and the patients were not institutionalised. The informa-
tion was obtained via telephone interview on the main
carer. The questionnaire was performed using a base
questionnaire of the “Trans-national analysis of the
socio-economic impact of AD in the European Union”
Project. The “Clinical Dementia Rating” (CDR) was used
for controlling the severity of the disease. This clinical
score classify the severity of the disease into three levels:
mild-moderate and severe. Fieldwork was carried out in
2001 [18]. The study was approved by the Ethics
Research Committee of University Hospital Nuestra Sra.
de la Candelaria.
The observational study on HIV/AIDS was performed
as a multi-centre study in the Canary Islands using a
sample of 569 patients recruited at outpatient visits. The
study was approved by the Ethics Research Committee
of University Hospital Nuestra Sra. de la Candelaria.
Demographic and clinical data were obtained from four
hospitals offering HIV outpatient services in the Canary
Islands. Potential participants were randomly selected
from clinical records. Patients at least 18 years old were
interviewed following outpatient visits at the hospitals’
centres for infectious diseases. Fieldwork was carried
out between January and December, 2003 [19]. The
selected criteria to create the groups in the HIV
research were proposed by the Center of Disease Con-
trol and Prevention (CDC). CDC distinguishes between
the following phases of disease: asymptomatic HIV,
symptomatic HIV and AIDS. Unfortunately, it was not
possible to distinguish between different levels of sever-
ity for diagnosed diseases in the Canary Island Health
Survey.
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cross-sectional study with a sample of 423 people diag-
nosed with stroke receiving outpatient care. Patients
were recruited from five hospitals in the Canary Islands,
Spain, according the year the suffered the stroke and
were divided into three categories: first, second and three
years survivors. The fieldwork was carried out between
January and December 2004. Demographic and clinical
data were collected for patients previously diagnosed
with stroke or their caregivers as proxies [20]. The study
was approved by the Ethics Research Committee of Uni-
versity Hospital Nuestra Sra. de la Candelaria.
Health Related Quality Of Life (HRQOL) was mea-
sured in CIHS and the three observational studies
through a generic measure, the EQ-5 D questionnaire
[21.22]. The EQ-5 D has five questions asking for a self-
perceived status of five different functional conditions
related to mobility, personal care, daily activities, pain/
discomfort and anxiety/depression. In each dimension,
the interviewed person can choose between three possi-
ble answers: ‘absence of problems’, ‘moderate problems’
and ‘incapacity to perform the activity or severe pro-
blems’. A respondent health status is defined by combin-
ing one level from each of the 5 dimensions (EQ-5D). A
total of 243 possible health statuses can be defined in this
way. HRQOL (EQ-5D) of AD patients were assessed by
the patients’ caregivers, as well as in the case of stroke
patients with affected level of consciousness.
In order to translate this number to a single health
score,a‘preferences index score or tariff’ is needed.
Actually, there are two alternative index scores or tariffs
validated in Spain, the first one based on a visual analo-
gue scale (the VAS index score or tariff) and the second
o n eb a s e do nt h et i m et r a d e - o f f( T T Oi n d e xs c o r eo r
tariff [23]). The results derived from both index scores
or tariffs are not directly comparable in spite of some
attempts to connect them [24]. The TTO scale is fre-
quently used, and considered a suitable alternative in
the literature [25,26] because preferences are usually
observed through choices between alternatives health
states. The results are displayed using TTO index tariffs
and the observed values in the VAS thermometer.
We performed a statistical descriptive analysis. Apart
from age and sex, there were no common variables in
the four databases used. Due to this fact, a multivariate
analysis was unfeasible. Therefore, the study described
the situation of people with diagnosed diseases, but we
could not analyse the associations between those illness
and other health factors like education, income status,
social class, habits, etc.
Results
Tables 1 and 2 show the presence of moderate-severe
restrictions in different Health Related Quality of Life
dimensions associated to the identified diseases, com-
pared with the general population. Table 3 contains
TTO index scores or tariffs results for people that suffer
specific diseases and table 4 shows the corresponding
index scores or tariffs for general population. Finally,
Tables 5 and 6 display the results obtained through the
visual analogue scale-thermometer for people that suffer
a specific diseases and for the general population.
Depression/anxiety is the most affected dimension of
HRQOL for HIV and anxiety/depression patients, repre-
senting a relative younger patient group. In the Alzhei-
mer’s disease (AD), the high percentage of moderate-
severe problems stands out in each one of the five
dimensions (5D), especially in usual activities and in self
care, 95% and 85% respectively. Stroke patients also pre-
sent high percentages of severe-moderate problem in all
dimensions, over the 50% in most cases. Osteomuscular
diseases (rheumatism; arthritis; degenerative osteoarthritis;
osteoporosis and back pain) show a similar prevalence of
severe-moderate problems in the five dimensions, being
pain/discomfort the most problematic dimension in peo-
ple that suffer these diseases. Regarding other studied dis-
eases such as diabetes, heart problems, anxiety/depression,
respiratory and digestive diseases, severe-moderate pro-
blems are mainly present in pain-discomfort and depres-
sion/anxiety dimensions.
Focusing on disease progression, HIV and AD show a
similar pattern: the higher the disease severity the higher
the complications rate. However, the condition of
patients who survive a stroke does not improve with
time. On the contrary, the health status seems to get
worse (see table 1).
As expected, comparing the results of general popula-
tion (see table 2) with the results obtained for people
that suffer each specific disease, it can be observed a
higher percentage of people reporting moderate or
severe problems in different Health Related Quality of
Life dimensions for all diseases than in general popula-
tion (up to 10 percentage points in 4 of the 5 studied
dimensions). Alzheimer’s disease and Stroke patients
suffer the highest loss in HRQOL, with differences
exceeding 30 percentage points in 3 of the 5 dimen-
sions. AD is the most remarkable case of HRQOL loss
due to the existing differences between patients and
general population, approximately 60 percentage points
in self-care and usual activities. The percentage of peo-
ple that survive a stroke reporting moderate or severe
problems in different HRQOL dimensions is remarkable.
Likewise, rheumatism and diabetes show differences in
problems reported in the five dimensions of 10 percen-
tage points. Digestive and heart problems present this
type of differences in problems reported in 3 of the 5
dimensions. People that suffer other diseases reported
lower differences in moderate or severe problems in
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Page 3 of 9Table 1 Percentage of people that suffer a specific disease reporting moderate or severe problems in different Health
Related Quality of Life dimensions
Average Age
(sd)
Mobility Self-
care
Usual
activities
Pain/
Discomfort
Depression/
Anxiety
HIV+
i 40.4(8.1) 18.32% 4.60% 27.94% 44.75% 51.74%
HIV-asymptomatic 39.5 (7.8) 15.50% 4.69% 23.44% 42.19% 49.41%
HIV-symptomatic 40.6 (8.1) 14.49% 5.07% 28.26% 41.61% 46.76%
AIDS 41.8 (8.7) 26.67% 4.03% 35.33% 52.00% 60.26%
Alzheimer disease
ii 75.5 (8.5) 68.86% 84.49% 95.10% 68.57% 73.47%
AD mild 73.7 (7.1) 38.78% 63.27% 93.88% 65.31% 81.63%
AD medium 75.4 (8.6) 67.03% 90.11% 95.60% 68.13% 73.63%
AD severe 76.6 (9.3) 87.63% 96.91% 98.97% 71.13% 69.07%
Stroke
iii 66.9 (12.2) 63.01% 48.39% 64.24% 71.00% 65.90%
Stroke survivor first year 67.2 (11.6) 56.99% 46.24% 64.89% 68.13% 64.13%
Stroke survivor second year 67.1 (12.5) 63.00% 49.49% 64.88% 72.64% 66.33%
Stroke survivor three or more years 66.4 (12.1) 66.90% 48.28% 6.45% 70.55% 66.43%
Diabetes Mellitus
iv 63.8 (13.8) 38.02% 15.70% 35.64% 62.98% 43.06%
Rheumatism; arthritis; degenerative
osteoarthritis
iv
62.4 (14.9) 41.37% 14.26% 33.24% 71.65% 46.25%
Back pain
iv 53.8 (17.3) 28.66% 10.49% 26.17% 61.22% 43.11%
Heart problems
iv 66.1 (16.3) 43.53% 20.65% 38.94% 62.83% 46.45%
Osteoporosis
iv 66.3 (12.2) 46.31% 19.70% 37.44% 75.62% 55.28%
Anxiety/depression
4v 53.2 (17.3) 29.52% 10.62% 28.39% 64.56% 70.98%
Respiratory Tract Diseases
iv 54.8 (19.7) 33.18% 9.81% 31.31% 58.21% 38.86%
Digestive diseases
iv 52.0 (17.7) 27.87% 8.40% 23.62% 58.93% 43.69%
Sources:
i Observational study on HIV/AIDS (19);
ii Observational study on Alzheimer’s disease (18);
iii Observational study on Stroke (20);
iv Canary Island Health
Survey.
Table 2 Canary Island General population-Percentage of people reporting moderate or severe problems in different
Health Related Quality of Life dimensions
Population Mobility Self-care Usual activities Pain/Discomfort Depression/Anxiety
General population 16.18% 5.63% 13.19% 36.38% 27.03%
General population (men) 13.16% 4.73% 10.70% 27.98% 17.94%
General population
(women)
18.20% 6.27% 14.97% 42.36% 33.52%
General population
Age 16-44
4.19% 1.21% 4.05% 22.36% 19.70%
General population
Age 45-65
17.63% 4.13% 14.13% 42.99% 32.90%
General population
Age ≥ 65
40.08% 16.80% 31.58% 58.72% 35.99%
General population
Seniors I
Age 66-74
35.27% 10.04% 24.77% 56.18% 34.31%
General population
Seniors II
Age 75-84
45.51% 22.60% 36.84% 63.75% 38.36%
General population
Seniors III
Age ≥ 85
61.54% 48.72% 66.67% 60.53% 38.36%
Source: own elaboration from Canary Island Health Survey.
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Page 4 of 9Table 3 Canarian Population that suffer a specific disease
Population Sample Average Standard
deviation
Percentile
25%
Percentile
50%
Percentile
75%
HIV+
i 538 0.810400 0.2464732 0.749 0.8771 1
HIV-asymptomatic 255 0.8270694 0.2362902 0.7814 0.9095 1
HIV-symptomatic 136 0.8375243 0.2075094 0.749 0.9095 1
AIDS 147 0.7563361 0.2870125 0.6533 0.8644 1
Alzheimer disease
ii 237 0.0958835 0.3872881 -0.153 0.0279 0.3388
AD mild 49 0.524851 0.2501451 0.2558 0.6022 0.7485
AD medium 91 0.1817604 0.3133704 -0.068 0.1095 0.3388
AD severe 97 -0.2013763 0.2349101 -0.395 -0.241 -0.017
Stroke
iii 423 0.4718158 0.4388945 0.0658 0.5698 0.8265
Stroke survivor first year 89 0.4960685 0.4245884 0.1485 0.6149 0.8265
Stroke survivor second year 193 0.4696021 0.4407007 0.0607 0.5698 0.8644
Stroke survivor three or more years 141 0.4596021 0.4474767 0.1095 0.5698 0.8265
Diabetes Mellitus
iv 358 0.6934785 0.3270208 0.5192 0.8265 1
Rheumatism; arthritis; degenerative
osteoarthritis
iv
1009 0.6874559 0.312844 0.5192 0.7996 0.8771
Back pain
iv 997 0.7334693 0.3111258 0.5388 0.8771 1
Heart problems
iv 336 0.6876655 0.3224886 0.5192 0.78415 0.9095
Osteoporosis
iv 198 0.6325652 0.3275672 0.4186 0.7308 0.8771
Anxiety/depression
4v 717 0.6630417 0.323674 0.4558 0.8265 0.9095
Respiratory Tract Diseases
iv 210 0.7075705 0.3278174 0.5192 0.8265 1
Digestive diseases
iv 481 0.7360424 0.3092 0.5698 0.8644 1
EQ-5D-Spanish TTO index score or tariff.
Sources:
i Observational study on HIV/AIDS (19);
ii Observational study on Alzheimer’s disease (18);
iii Observational study on Stroke (20);
iv Canary Island Health
Survey.
Table 4 Canary Island General population- EQ-5D-Spanish TTO Tariff
Population Sample Average Standard deviation Percentile 25% Percentile 50% Percentile 75%
General population 4282 0.8509447 0.2497144 0.8265 1 1
General population (men) 1783 0.8882825 0.224256 0.8771 1 1
General population
(women)
2499 0.8243046 0.2632207 0.7869 0.9095 1
General population
Age 16-44
2140 0.9226352 0.1678222 0.9095 1 1
General population
Age 45-64
1156 0.824119 0.2572352 0.7869 0.9095 1
General population
Age ≥ 65
986 0.7267993 0.3237708 0.5967 0.8265 1
General population
Seniors I
Age 65-74
598 0.7700843 0.2865273 0.7039 0.8771 1
General population
Seniors II
Age 75-84
316 0.6822646 0.3520769 0.5192 0.8265 1
General population
Seniors III
Age ≥ 85
72 0.5627514 0.4026511 0.33045 0.6528 0.87985
Source: own elaboration from Canary Island Health Survey.
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Population Sample Average Standard
deviation
Percentile
25%
Percentile
50%
Percentile
75%
HIV+
i 519 71.14258 21.83456 60 75 90
HIV-asymptomatic 249 74.46185 21.20806 60 80 90
HIV-symptomatic 133 66.68421 24.70902 55 70 85
AIDS 137 69.43796 18.98795 55 70 80
Alzheimer disease
ii 237 40.98312 19.47618 30 40 50
AD mild 49 52.20408 18.61449 40 50 60
AD medium 91 42.8022 17.08165 30 45 50
AD severe 97 33.60825 19.06161 20 35 50
Stroke
iii 423 53.68618 26.28795 35 50 75
Stroke survivor first year 89 55.95556 26.62301 40 60 70
Stroke survivor second year 193 51.64433 27.04482 30 50 70
Stroke survivor three or more years 141 55.02797 24.98082 40 50 80
Diabetes Mellitus
iv 342 47.81871 27.34437 30 50 70
Rheumatism; arthritis; degenerative
osteoarthritis
iv
953 47.28122 28.06338 20 50 70
Back pain
iv 956 50.91109 29.65606 25 55 75
Heart problems
iv 308 47.30519 27.43576 20 50 65
Osteoporosis
iv 196 45.61735 27.10741 20 50 70
Anxiety/depression
4v 676 48.43195 28.91151 20 50 70
Respiratory Tract Diseases
iv 202 49.98515 28.27661 30 50 70
Digestive diseases
iv 474 50.32068 30.08477 10 58 75
Visual Analogical Scale (thermometer).
Sources:
i Observational study on HIV/AIDS (19);
ii Observational study on Alzheimer’s disease (18);
iii Observational study on Stroke (20);
iv Canary Island Health
Survey.
Table 6 Canary Island general population
Population Sample Average Standard deviation Percentile 25% Percentile 50% Percentile 75%
General population 4176 59.3125 30.99565 40 70 80
General population (men) 1739 64.64347 29.17882 50 75 85
General population
(women)
2437 55.50841 31.69165 30 60 80
General population
Age 16-44
2128 65.04229 31.28681 50 80 90
General population
Age 45-65
1130 56.4177 30.0071 40 65 80
General population
Age ≥ 65
918 49.59368 28.5296 25 50 70
General population
Seniors I
Age 65-74
568 50.27641 28.75174 30 55 70
General population
Seniors II
Age 75-84
300 49.15 28.46545 20 55 70
General population
Seniors III
Age ≥ 85
50 44.5 26.25172 20 50 63
Visual Analogical Scale (thermometer).
Source: own elaboration from Canary Island Health Survey.
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population.
The most discouraging results in percentile analysis
correspond to AD. Table 3 shows that the best group of
AD patients, percentile 75, has a low TTO value,
0.3388, and this index score or tariff takes a negative
value in percentiles 25. Stroke results show that some
patients in the percentile 75 almost recover the normal
QOL after stroke; however, a considerable number of
patients (percentiles 50 and 25), suffered severe conse-
quences after the cerebrovascular accident. HIV/AIDS
results are fairly better compared with other diseases. In
the other diseases, we observe a progressive loss of QOL
compared to general population, that is, that percentile
75 shows a similar behaviour, whereas percentile 25 has
values that are slightly lower. On the one hand, percen-
tile 75 of HIV, diabetes, back pain, respiratory and
digestive disease seems to have a similar QOL compared
to general population. On the other hand, rheumatism,
heart problems, osteoporosis and anxiety have after-
effects and show differences of about a 10 percentage
points in percentile 75 (see tables 3 and 4).
Results obtained by VAS method for specific diseases
and general population are similar to TTO ones (see
tables 5 and 6). AD has again the lowest values in VAS
results but these numbers are higher than those
obtained by TTO method for AD. This situation recurs
i nt h es t r o k ec a s e .I nt h ec a s eo fa n x i e t y / d e p r e s s i o n ,
back pain and rheumatism, the loss of QOL is progres-
sive; that is, there is small differences between QOL of
general population and people with specific diseases
who reported better health status (up to 5-10 points
approximately in percentile 75) and this difference
increases in people who reported worse health status
(up to 15-20 points in percentile 25). Osteoporosis
shows also a progressive pattern with a slight difference,
a group of patients, percentile 75, maintain the QOL of
general population. Percentile 75 and 50 of digestive dis-
ease show that an important number of patients that
almost maintain a normal life, whereas patients in per-
centile 25 suffer severe consequences. Diabetes, heart
problems and respiratory diseases patients have a loss of
QOL that is constant across the percentile analysis, or
slightly increases in percentile 25.
Discussion and conclusions
Over the years, there has been a progressive interest in
listening user’s and citizens’ voice in different aspects of
the delivery of health services. The identification and
assessment of HRQOL of patients and the general popu-
lation are a promising way of achieving this goal. Health
surveys offer the opportunity to monitor population’s
health problems by means of validated instruments and
to assess its potential impact on HRQOL. From a public
health perspective, such monitoring allows the identifi-
cation of potential changes in prevalence and inequal-
ities on health status, and reveals unmet needs in the
community [27].
The impact of health state changes on an individual’s
quality of life has gained increased attention in social
and medical clinical research [28]. There is an extended
acknowledgement that “classic” measurement of health
as expectancy of life and morbidity rates should be com-
plemented, especially in developed countries with a high
and increasing prevalence of chronic conditions, by
Health Related Quality of Life measurements.
The Canary Island Health Survey gives an overview of
the Canary citizens’ health status to joining two types of
indicators: self perceived health status (HRQOL) and
chronic conditions (self-reported, but based on known
medical diagnosis). However, this useful information
should be complemented with “ad hoc” studies focused
on diseases with strong health and social impact but low
rates of prevalence.
In this work, we show that depression/anxiety and
pain/discomfort are the most affected dimensions in the
Canary population that suffer a chronic disease. The
progression pattern observed is the higher severity of
disease higher probability of reporting moderate or
severe problems in different HRQOL dimensions, with
the exception of stroke patients that don’t seem to
improve with the passage of time.
The HRQOL monitoring in the general population
requires generic instruments that ideally capture all-
important aspects of self perceived health, allowing
comparisons within and between populations. The com-
bination of EQ-5 D with any other specific scales should
be carefully considered. Specific measurements bring
into focus the burden on health and functioning for a
health condition or treatment. Generic HRQOL mea-
surements are intended to provide information on gen-
eral function and well-being with the advantage of
allowing comparisons among different diseases or popu-
lations. Besides EQ-5 D can be used to estimate and
compare self-perceived effectiveness and cost-effective-
ness of different health care interventions intended to
improve populations’ health [29-31]. Hence, the EQ-5 D
is one of the instruments most frequently used in cost
utility analysis for the development of QALYs in the
field of Health Technology Assessment [31]. Although
some countries have expressed criticism of the use of
QALYs in economic evaluation [32,33], the outcome
remains the most demanded by the rating agencies of
health interventions in most European countries [34-39].
In this sense, the measurement of populations’
HRQOL from a country or region and the study of its
evolution can be a useful tool for decision-makers. Self
perceived health status can contribute to complement
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dence and prevalence morbidity indicators. A complete
description on the health status of citizens can help to
an efficient allocation of health care and social resources
in order to satisfy the social needs. Besides, having a
synthetic indicator that combine expectancy and quality
of life make easier the comparison between costs and
consequences of implementing health policies. For
instance, policies to prevent infant obesity, restrictive
laws on tobacco and alcohol consumption, the imple-
mentation of integrated programmes on Ischemic Heart
Diseases, Tumours, Stroke, Mental Illness, Diabetes
Mellitus, or the expansion of another preventive pro-
grams, only for mentioning some of the most recent
health policies promoted by the Spanish Ministry of
Health and Social Policy jointly with regional authori-
ties. So, the measurement of self-perceived health of the
population using multidimensional concepts should be
considered as a relevant part of the development of
methods and tools that could help to a better under-
standing of the effectiveness of health care services and
to a more appropriated valuation of the returns of the
health care systems.
Certain limitations of this study should be discussed.
First, like most other studies on general population, our
analysis does not include institutionalized people. Sec-
ond, it can be argued that data on HRQOL are self-
reported and that fact limits its validity. However,
HRQOL is the way of getting information on subjective
aspects of health. So, as Sullivan (2003) [1] note “...
patient outcomes... are valid because they are subjec-
tive”. Third, illnesses were self-reported in CIHS.
Although, other studies show evidence of good agree-
ment between self-reporting and clinical diagnoses of
chronic diseases [40-42], the replies of people that had
been diagnosed can be affected by the accessibility or
availability of medical services when they were asked
about their diseases, . In second place, we have per-
formed a descriptive study instead of developing a statis-
tical model that helping to explain differences in
HRQOL between individuals. Unfortunately, we do not
h a v eac o l l e c t i o no fs a m ee x p l a n a t o r yv a r i a b l e si nt h e
observational studies and CIHS. Only age and sex/gen-
der and diagnosed diseases could have been used in this
analysis. For this reason, at the moment, we considered
more interesting to show, in a descriptive way, the
HRQOL of people that suffer a chronic disease in com-
parison with general population. Other studies analyzed
the association between HRQOL and socioeconomic
health determinants in Canary Island [43] using more
sophisticated statistical techniques [43]. Finally, the dif-
ferent data sources evaluated in the paper were devel-
oped at different time frames. Positive, or negative,
changes in health habits trends and the introduction of
new health care technologies can improve, or worse, the
health status of population and the self perceived health
status of people that suffer a certain disease. However,
in our study the differences between the dates where
studies and Canary Island Health Survey were developed
are small, from 2001 to 2004, and we would not expect
sharp change in self perceived health status of people
that suffer a certain disease.
Despite these limitations, this study shows a remark-
able loss of HRQOL in people that suffer a chronic dis-
ease compared to general population. These findings
stress the importance of disease prevention interventions
as well as the early detection (screening) and efficient
management of chronic conditions, in order to improve
HRQOL. Future research is needed for improving our
knowledge about explanatory variables that affect the
HRQOL of people along their lifetime.
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